4.7 Review

Sprouty and cancer: The first terms report

Journal

CANCER LETTERS
Volume 242, Issue 2, Pages 141-150

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2005.12.032

Keywords

Sprouty; cancer; tumour suppressor; tumour marker; Ras/Erk pathway; gene deregulation

Categories

Funding

  1. Medical Research Council [G0100100] Funding Source: Medline
  2. MRC [G0100100] Funding Source: UKRI
  3. Medical Research Council [G0100100] Funding Source: researchfish

Ask authors/readers for more resources

The Ras/Erk signaling pathway has a central role in development of multi-cellular organisms as well as in signal transmission in the mature individual. Recently, a family of genes, designated Sprouty, induced by the Ras/Erk pathway was found to specify proteins that inhibited the upstream pathway. Being in a position that is likely to control well-characterized oncogene products suggested that the expression levels of the Sprouty genes may be relevant in human carcinogenesis. Early data on the deregulation of Sprouty expression in breast, prostate and liver cancers is discussed along with the notion that some of them might have potential as tumour markers or that the derived proteins may act as tumour suppressors. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available